10-79559511-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001098668.4(SFTPA2):​c.-23-5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.802 in 1,434,494 control chromosomes in the GnomAD database, including 480,364 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.72 ( 39999 hom., cov: 28)
Exomes 𝑓: 0.81 ( 440365 hom. )

Consequence

SFTPA2
NM_001098668.4 splice_region, intron

Scores

2
Splicing: ADA: 0.7087
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.31

Publications

22 publications found
Variant links:
Genes affected
SFTPA2 (HGNC:10799): (surfactant protein A2) This gene is one of several genes encoding pulmonary-surfactant associated proteins (SFTPA) located on chromosome 10. Mutations in this gene and a highly similar gene located nearby, which affect the highly conserved carbohydrate recognition domain, are associated with idiopathic pulmonary fibrosis. The current version of the assembly displays only a single centromeric SFTPA gene pair rather than the two gene pairs shown in the previous assembly which were thought to have resulted from a duplication. [provided by RefSeq, Sep 2009]
SFTPA2 Gene-Disease associations (from GenCC):
  • interstitial lung disease 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • idiopathic pulmonary fibrosis
    Inheritance: Unknown, AD Classification: MODERATE, LIMITED Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 10-79559511-C-T is Benign according to our data. Variant chr10-79559511-C-T is described in ClinVar as [Benign]. Clinvar id is 1247340.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.786 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFTPA2NM_001098668.4 linkc.-23-5G>A splice_region_variant, intron_variant Intron 2 of 5 ENST00000372325.7 NP_001092138.1 Q8IWL1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFTPA2ENST00000372325.7 linkc.-23-5G>A splice_region_variant, intron_variant Intron 2 of 5 1 NM_001098668.4 ENSP00000361400.2 Q8IWL1

Frequencies

GnomAD3 genomes
AF:
0.724
AC:
109257
AN:
150818
Hom.:
39988
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.631
Gnomad AMI
AF:
0.869
Gnomad AMR
AF:
0.648
Gnomad ASJ
AF:
0.710
Gnomad EAS
AF:
0.739
Gnomad SAS
AF:
0.704
Gnomad FIN
AF:
0.770
Gnomad MID
AF:
0.661
Gnomad NFE
AF:
0.792
Gnomad OTH
AF:
0.702
GnomAD2 exomes
AF:
0.711
AC:
140999
AN:
198208
AF XY:
0.718
show subpopulations
Gnomad AFR exome
AF:
0.598
Gnomad AMR exome
AF:
0.579
Gnomad ASJ exome
AF:
0.711
Gnomad EAS exome
AF:
0.707
Gnomad FIN exome
AF:
0.770
Gnomad NFE exome
AF:
0.756
Gnomad OTH exome
AF:
0.706
GnomAD4 exome
AF:
0.811
AC:
1040736
AN:
1283558
Hom.:
440365
Cov.:
55
AF XY:
0.808
AC XY:
518094
AN XY:
640838
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.627
AC:
18748
AN:
29914
American (AMR)
AF:
0.625
AC:
24915
AN:
39856
Ashkenazi Jewish (ASJ)
AF:
0.722
AC:
17517
AN:
24268
East Asian (EAS)
AF:
0.765
AC:
28947
AN:
37848
South Asian (SAS)
AF:
0.740
AC:
59325
AN:
80180
European-Finnish (FIN)
AF:
0.766
AC:
39329
AN:
51346
Middle Eastern (MID)
AF:
0.666
AC:
3382
AN:
5080
European-Non Finnish (NFE)
AF:
0.839
AC:
806519
AN:
960830
Other (OTH)
AF:
0.775
AC:
42054
AN:
54236
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.379
Heterozygous variant carriers
0
7514
15029
22543
30058
37572
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16872
33744
50616
67488
84360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.724
AC:
109308
AN:
150936
Hom.:
39999
Cov.:
28
AF XY:
0.719
AC XY:
52971
AN XY:
73652
show subpopulations
African (AFR)
AF:
0.630
AC:
25911
AN:
41098
American (AMR)
AF:
0.647
AC:
9834
AN:
15198
Ashkenazi Jewish (ASJ)
AF:
0.710
AC:
2449
AN:
3450
East Asian (EAS)
AF:
0.738
AC:
3735
AN:
5060
South Asian (SAS)
AF:
0.705
AC:
3352
AN:
4756
European-Finnish (FIN)
AF:
0.770
AC:
8062
AN:
10464
Middle Eastern (MID)
AF:
0.670
AC:
197
AN:
294
European-Non Finnish (NFE)
AF:
0.792
AC:
53524
AN:
67620
Other (OTH)
AF:
0.697
AC:
1455
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
1328
2656
3983
5311
6639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.690
Hom.:
3793
Bravo
AF:
0.719

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23328842, 9003399) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Interstitial lung disease 2 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SFTPA2-related disorder Benign:1
Jul 01, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
15
DANN
Benign
0.61
PhyloP100
-1.3
PromoterAI
-0.047
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.71
dbscSNV1_RF
Benign
0.55
SpliceAI score (max)
0.63
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.63
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1650232; hg19: chr10-81319267; COSMIC: COSV64882523; API